KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Change in Accured Expenses (2017 - 2025)

Alnylam Pharmaceuticals' Change in Accured Expenses history spans 17 years, with the latest figure at -$174.9 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 181.54% year-over-year to -$174.9 million; the TTM value through Dec 2025 reached $75.1 million, down 17.59%, while the annual FY2025 figure was $75.1 million, 17.59% down from the prior year.
  • Change in Accured Expenses reached -$174.9 million in Q4 2025 per ALNY's latest filing, down from $223.5 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $223.5 million in Q3 2025 to a low of -$174.9 million in Q4 2025.
  • Average Change in Accured Expenses over 5 years is $26.4 million, with a median of $57.3 million recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: surged 324.26% in 2021, then tumbled 3101.17% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $39.5 million in 2021, then soared by 159.78% to $102.6 million in 2022, then plummeted by 137.68% to -$38.7 million in 2023, then crashed by 60.62% to -$62.1 million in 2024, then crashed by 181.54% to -$174.9 million in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Change in Accured Expenses are -$174.9 million (Q4 2025), $223.5 million (Q3 2025), and $182.1 million (Q2 2025).